Agios Pharmaceuticals Inc’s filing revealed that its Director Scadden David unloaded Company’s shares for reported $9256.0 on Dec 11 ’24. In the deal valued at $46.28 per share,200 shares were sold. As a result of this transaction, Scadden David now holds 15,483 shares worth roughly $0.65 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Washburn Theodore James Jr. sold 772 shares, generating $43,301 in total proceeds. Upon selling the shares at $56.09, the Principal Accounting Officer now owns 813 shares.
Before that, Ballal Rahul D. sold 10,000 shares. Agios Pharmaceuticals Inc shares valued at $581,911 were divested by the Director at a price of $58.19 per share. As a result of the transaction, Ballal Rahul D. now holds 7,992 shares, worth roughly $0.34 million.
Scotiabank initiated its Agios Pharmaceuticals Inc [AGIO] rating to a Sector outperform in a research note published recently. Leerink Partners also remained covering AGIO and has decreased its forecast on September 27, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on February 08, 2024. It rated AGIO as “an Overweight”.
Price Performance Review of AGIO
On Tuesday, Agios Pharmaceuticals Inc [NASDAQ:AGIO] saw its stock fall -1.71% to $41.96. Over the last five days, the stock has lost -8.82%. Agios Pharmaceuticals Inc shares have risen nearly 88.41% since the year began. Nevertheless, the stocks have risen 80.55% over the past one year. While a 52-week high of $62.58 was reached on 11/11/24, a 52-week low of $20.96 was recorded on 01/19/24. SMA at 50 days reached $49.73, while 200 days put it at $42.08.
Levels Of Support And Resistance For AGIO Stock
The 24-hour chart illustrates a support level at 40.79, which if violated will result in even more drops to 39.63. On the upside, there is a resistance level at 42.98. A further resistance level may holdings at 44.01. The Relative Strength Index (RSI) on the 14-day chart is 35.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -9.91, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.15%. Stochastics %K at 15.86% indicates the stock is a buying.
How much short interest is there in Agios Pharmaceuticals Inc?
A steep rise in short interest was recorded in Agios Pharmaceuticals Inc stocks on 2024-11-29, growing by 0.23 million shares to a total of 4.57 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 4.34 million shares. There was a rise of 5.13%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 03, 2023 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $41 price target.
